Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Reed Cory JPres, Life Sol Cust Sup & S.M. | Option exercise · 10b5-1 plan | M | — 12.0K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 0 | Mahdessian AraDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 32.0K sh | Jan 15, 2026 traded Jan 15, 2026 |
| 0 | Sijbrandij SytseDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 54.3K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 12.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Morris DonnaExecutive Vice President | Grant or award · 10b5-1 plan | A | — 15.1K sh | Jan 15, 2026 traded Jan 14, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Jan 15, 2026 traded Jan 13, 2026 |
| 51 | Feinberg PeterDirector | Open-market purchase | BUY | $87K 20.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 49 | Hildebrandt John DPresident and COO | Open-market sale | SELL | $1.02M 7,421 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 48 | DiGravio Karen AnnTrustee | Open-market purchase | BUY | $3,062 378 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 46 | Infante Beatriz VDirector | Open-market sale | SELL | $273K 1,995 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 46 | Kovaleski PaulEVP-Chief Merch. Officer | Open-market sale | SELL | $582K 4,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 44 | Brumana RodrigoChief Financial Officer | Open-market sale | SELL | $7,756 523 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 43 | Baller LanceDirector, 10% Owner | Open-market purchase | BUY | $14K 6,192 sh | Jan 14, 2026 traded Dec 18, 2025 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | Open-market sale | SELL | $1.45M 90.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner | Open-market purchase | BUY | $204K 11 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Open-market sale | SELL | $1.37M 49.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | Open-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer | Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Frank MalcolmDirector | Open-market sale | SELL | $452K 1,527 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $63K 176 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | Open-market sale | SELL | $205K 1,499 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | DiGravio Karen AnnTrustee | Open-market purchase | BUY | $1,274 213 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 38 | Allison EricChief Product Officer | Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |